Suraksha Diagnostic IPO: A Worthy Investment?

Suraksha Diagnostic’s IPO has caught investors’ attention, with Anand Rathi’s analysis highlighting its strong presence in Eastern India and potential for growth in the healthcare sector. However, profitability concerns and stiff competition are key risks to consider. Investors are advised to weigh the company’s expansion plans and sector prospects against its financial performance before subscribing. It’s a balanced opportunity for those with a long-term perspective.